-
5021por Garcia, Andreza R., Oliveira, Danielle M. P., Claudia F. Amaral, Ana, Jesus, Jéssica B., Rennó Sodero, Ana Carolina, Souza, Alessandra M. T., Supuran, Claudiu T., Vermelho, Alane B., Rodrigues, Igor A., Pinheiro, Anderson S.“…Altogether, our results broaden the current spectrum of known arginase inhibitors and revealed promising drug candidates for the therapy of visceral leishmaniasis.…”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
5022“…This summary includes overall biotechnological applications, insights into its protein expression machinery (especially on glycoprotein and antibody fragment expression), available expression vectors, cell culture conditions, and its potential as an immunotherapy agent for human leishmaniasis treatment. Furthermore, we will highlight useful online tools and, finally, discuss possible future applications such as the humanization of the glycosylation profile of L. tarentolae or the expression of mammalian recombinant proteins in amastigote-like cells of this species or in amastigotes of avirulent human-pathogenic Leishmania species.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
5023“…Leishmaniasis caused by obligate intracellular parasites of genus Leishmania is one of the most neglected tropical diseases threatening 350 million people worldwide. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
5024por AHMADI, Mohammad, AKBARI, Ziba, ALIKHANI, Mahbobeh, HAJHOSSIANI, Reza, ZAMANI, Zahra, ARJMAND, Mohammad“…It has been used traditionally to treat trypanosomiasis, malaria fever, eczema, cancer, ulcer, fever, herpes headache, and skin lesion such as leishmaniasis. In this preliminary study, nuclear magnetic resonance (NMR)-metabolomics approaches was used to evaluate the inhibitory effects and metabolic alterations caused by leaf extract of X. strumarium on the stationary phases of promastigotes in Leishmania major. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
5025por Van Bockstal, Lieselotte, Sádlová, Jovana, Suau, Hamide Aslan, Hendrickx, Sarah, Meneses, Claudio, Kamhawi, Shaden, Volf, Petr, Maes, Louis, Caljon, Guy“…OBJECTIVES: To gain insight into the propagation of miltefosine (MIL) resistance in visceral leishmaniasis, this laboratory study explored development of resistant parasites with a defective miltefosine transporter (MT) in sand flies. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
5026por Mendes Costa, David, Cecílio, Pedro, Santarém, Nuno, Cordeiro-da-Silva, Anabela, Tavares, Joana“…Leishmaniasis is an important vector-borne neglected tropical disease caused by Leishmania parasites. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
5027por Mendes, Edinéia Pastro, Goulart, Carla Marins, Chaves, Otávio Augusto, Faiões, Viviane dos S., Canto-Carvalho, Marilene M., Machado, Gerzia C., Torres-Santos, Eduardo Caio, Echevarria, Aurea“…The results of antiparasitic effects against L. amazonensis revealed the chalcone-thiosemicarbazone class to be novel prototypes for drug development against leishmaniasis.…”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
5028“…Parasitic infections like leishmaniasis and trypanosomiasis remain as a worldwide concern to public health. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
5029por Phakeovilay, Chiobouaphong, Bourgeade-Delmas, Sandra, Perio, Pierre, Valentin, Alexis, Chassagne, François, Deharo, Eric, Reybier, Karine, Marti, Guillaume“…With an estimated annual incidence of one million cases, leishmaniasis is one of the top five vector-borne diseases. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
5030“…Leishmaniasis is caused by the flagellated protozoan Leishmania, and is a neglected tropical disease (NTD), as defined by the World Health Organisation (WHO). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
5031por López-Arencibia, Atteneri, San Nicolás-Hernández, Desirée, Bethencourt-Estrella, Carlos J., Sifaoui, Ines, Reyes-Batlle, María, Rodríguez-Expósito, Rubén L., Rizo-Liendo, Aitor, Lorenzo-Morales, Jacob, Bazzocchi, Isabel L., Piñero, José E., Jiménez, Ignacio A.“…Leishmaniasis and American trypanosomiasis are parasitic diseases that cause significant clinical, social and economic impact on the population of tropical and subtropical countries. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
5032por Wilson, Anne L., Courtenay, Orin, Kelly-Hope, Louise A., Scott, Thomas W., Takken, Willem, Torr, Steve J., Lindsay, Steve W.“…Vector-borne diseases (VBDs) such as malaria, dengue, and leishmaniasis exert a huge burden of morbidity and mortality worldwide, particularly affecting the poorest of the poor. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
5033por Meneses, Gdayllon Cavalcante, da Silva, Geraldo Bezerra, Tôrres, Paulo Pacelli Bezerra Filizola, de Castro, Valeska Queiroz, Lopes, Renata Lima, Martins, Alice Maria Costa, Daher, Elizabeth De Francesco“…Since 2011, our group has been studying renal biomarkers in visceral and cutaneous leishmaniasis, schistosomiasis, leptospirosis and leprosy. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
5034por Cianni, Lorenzo, Lemke, Carina, Gilberg, Erik, Feldmann, Christian, Rosini, Fabiana, Rocho, Fernanda dos Reis, Ribeiro, Jean F. R., Tezuka, Daiane Y., Lopes, Carla D., de Albuquerque, Sérgio, Bajorath, Jürgen, Laufer, Stefan, Leitão, Andrei, Gütschow, Michael, Montanari, Carlos A.“…The same series was evaluated on a panel of four human cysteine proteases (CatB, CatK, CatL, CatS) and Leishmania mexicana CPB, which is a potential target for the treatment of cutaneous leishmaniasis. The synthesized compounds are dipeptidyl nitriles designed based on the most promising combinations of different moieties in P1 (ten), P2 (six), and P3 (four different building blocks). …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
5035por Wall, Richard J., Carvalho, Sandra, Milne, Rachel, Bueren-Calabuig, Juan A., Moniz, Sonia, Cantizani-Perez, Juan, MacLean, Lorna, Kessler, Albane, Cotillo, Ignacio, Sastry, Lalitha, Manthri, Sujatha, Patterson, Stephen, Zuccotto, Fabio, Thompson, Stephen, Martin, Julio, Marco, Maria, Miles, Timothy J., De Rycker, Manu, Thomas, Michael G., Fairlamb, Alan H., Gilbert, Ian H., Wyllie, Susan“…[Image: see text] Available treatments for Chagas’ disease and visceral leishmaniasis are inadequate, and there is a pressing need for new therapeutics. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
5036“…Tuberculosis, malaria, pneumonia, visceral leishmaniasis, enteric fever and hemorrhagic fever are the most common etiologies in severely infected travelers and migrants. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
5037por Reine, Nyssa J“…The canine diseases considered in this paper include babesiosis (Babesia canis and B. gibsonii,) ehrlichiosis (E. canis and E. ewingii), anaplasmosis (A. phagocytophilum), neorickettsiosis (N. risticii var. atypicalis), leishmaniasis (Leishmania donovani complex), brucellosis (Brucella canis), hemoplasmosis (M. hemocanis, previously canine hemobartonellosis), and bartonellosis (Bartonella vinsonii).…”
Publicado 2004
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
5038por Rao, Srinivasa P S, Lakshminarayana, Suresh B, Jiricek, Jan, Kaiser, Marcel, Ritchie, Ryan, Myburgh, Elmarie, Supek, Frantisek, Tuntland, Tove, Nagle, Advait, Molteni, Valentina, Mäser, Pascal, Mottram, Jeremy C, Barrett, Michael P, Diagana, Thierry T“…Previously, we reported the discovery of the triazolopyrimidine (TP) class as selective kinetoplastid proteasome inhibitors with in vivo efficacy in mouse models of leishmaniasis, Chagas Disease and African trypanosomiasis (HAT). …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
5039por da Silva, Aurea V. A., de Souza, Tainã L., Figueiredo, Fabiano B., Mendes, Artur A. V., Ferreira, Luiz C., Filgueira, Camila P. B., Cuervo, Patricia, Porrozzi, Renato, Menezes, Rodrigo C., Morgado, Fernanda N.“…INTRODUCTION: In canine visceral leishmaniasis (CVL), lymphopenia, and the disorganization of lymphoid organs such as spleen and lymph nodes have been demonstrated. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
5040por Phan, Trong-Nhat, Baek, Kyung-Hwa, Lee, Nakyung, Byun, Soo Young, Shum, David, No, Joo Hwan“…The results of a visceral leishmaniasis mouse model indicated that treatment with Torin2, dactolisib, or NVP-BGT226 resulted in reductions of 35%, 53%, and 54%, respectively, in the numbers of liver parasites. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto